Histone methyltransferases (HMTs) are enzymes that add methyl groups to histone proteins. This methylation can either activate or repress gene expression, depending on the specific histone residues and the number of methyl groups added. Dysregulation of HMT activity has been implicated in numerous diseases, including cancer and neurological disorders.